Evaluation of point-of-care activated partial thromboplastin time testing by comparison to laboratory-based assay for control of intravenous heparin.

Journal article

INTRODUCTION: Patients on intravenous heparin require regular activated partial thromboplastin time monitoring. Laboratory-based activated partial thromboplastin time assays necessitate a delay between blood sampling and dose adjustment. Point-of-care testing could permit immediate dose adjustments, potentially enabling tighter control of anticoagulation. AIM: To assess equivalence of activated partial thromboplastin time measured by conventional laboratory assay and by a novel proprietary p...

Expand abstract

Authors: Douglas, A; Jefferis, J; Sharma, R; Parker, R; Handa, A

• Publication status: Published
• Journal: Angiology
• Volume: 60
• Issue: 3
• Pages: 358-361
• Publication date: 2009-01-01
• DOI: 10.1177/0003319709332958
• EISSN: 1940-1574
• ISSN: 0003-3197
• Language: English
• Keywords: Infusions, Intravenous; Humans; Point-of-Care Systems; Postoperative Complications; Partial Thromboplastin Time; Reproducibility of Results; Reference Standards; Heparin; Vascular Surgical Procedures; Clinical Laboratory Techniques; Surgery Department, Hospital